CTNNB1 and ependymoma: We observed that 25% (15/60) of ependymomas were C11orf95::RELA (now, ZFTA::RELA) fusion positive33 and that 68% (21⁄31) of craniopharyngiomas contained CTNNB1 mutations (Figure 2D).